Clinical Trials Browser

Phase 2 × Chordoma × Cetuximab × Clear all

NCT05041127 2026-02-19

Cetuximab for the Treatment of Advanced Unresectable or Metastatic Chordoma

Phase 2 Active not recruiting

Chordoma